Concepedia

Incidence and risk factors of contrast-induced nephropathy after transcatheter arterial chemoembolization in hepatocellular carcinoma

Mari Aoe, Takafumi Kanemitsu, Takamasa Ohki, Satoru Kishi, Yoshiyasu Ogura, Yuto Takenaka, Toyohiro Hashiba, Hiroko Ambe, Emi Furukawa, Yu Kurata,

Clinical and Experimental Nephrology · 2019 · 11 citations · 16 references

DOI

Concepts

References

16

Revised Equations for Estimated GFR From Serum Creatinine in Japan

Seiichi Matsuo, Enyu Imai, Masaru Horio et al. · American Journal of Kidney Diseases · 2009 · 6.4K citations

, , +9

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Josep M. Llovet, María Isabel Real, Xavier Montañá et al. · The Lancet · 2002 · 3.5K citations

, , +16

Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)

John A. Kellum, Norbert Lameire · Critical Care · 2013 · 2.8K citations · Full text

, , +16

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Chung‐Mau Lo, Wai‐Kuen Tso, Chi‐Leung Liu et al. · Hepatology · 2002 · 2.6K citations · Full text

, , +16

Contemporary Incidence, Predictors, and Outcomes of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions

Thomas T. Tsai, Uptal D. Patel, Tara I. Chang et al. · JACC: Cardiovascular Interventions · 2014 · 597 citations

, , +14